Biora Therapeutics, Inc. (BIOR)
NASDAQ: BIOR · IEX Real-Time Price · USD
0.730
-0.008 (-1.03%)
At close: May 17, 2024, 4:00 PM
0.749
+0.019 (2.63%)
After-hours: May 17, 2024, 7:53 PM EDT
Biora Therapeutics Stock Forecast
BIOR's stock price has decreased by -78.02% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Biora Therapeutics stock has a target of 15, which predicts an increase of 1,955.64% from the current stock price of 0.73.
Analyst Consensus: Strong Buy
Analyst Ratings
According to 1 stock analyst, the rating for BIOR is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +1,955.64% | May 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +6,752.13% | Jan 2, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $65 → $50 | Strong Buy | Maintains | $65 → $50 | +6,752.13% | Oct 2, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $65 | Strong Buy | Reiterates | $65 | +8,807.77% | Aug 15, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $65 | Strong Buy | Reiterates | $65 | +8,807.77% | Jul 27, 2023 |
Financial Forecast
Revenue This Year
1.79M
from 4.00K
Increased by 44,600.00%
Revenue Next Year
4.34M
from 1.79M
Increased by 142.62%
EPS This Year
-2.10
from -7.87
EPS Next Year
-2.05
from -2.10
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 3.7M | 8.9M | 9.6M |
| Avg | 1.8M | 4.3M | 9.3M |
| Low | 5,880 | 4,900 | 8.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 91,775.0% | 399.2% | 120.3% |
| Avg | 44,600.0% | 142.6% | 114.0% |
| Low | 47.0% | -99.7% | 105.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.05 | -0.98 | -2.81 |
| Avg | -2.10 | -2.05 | -2.73 |
| Low | -3.05 | -3.02 | -2.63 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.